BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17554019)

  • 61. Binding specificity of cyclic adenosine 3',5'-monophosphate-responsive element (CRE)-binding proteins and activating transcription factors to naturally occurring CRE sequence variants.
    Drust DS; Troccoli NM; Jameson JL
    Mol Endocrinol; 1991 Oct; 5(10):1541-51. PubMed ID: 1837842
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6.
    Flamand L; Menezes J
    J Virol; 1996 Mar; 70(3):1784-91. PubMed ID: 8627701
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
    Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
    J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
    [TBL] [Abstract][Full Text] [Related]  

  • 64. ATF1 and CREB trans-activate a cell cycle regulated histone H4 gene at a distal nuclear matrix associated promoter element.
    Guo B; Stein JL; van Wijnen AJ; Stein GS
    Biochemistry; 1997 Nov; 36(47):14447-55. PubMed ID: 9398163
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.
    Pegman PM; Smith SM; D'Souza BN; Loughran ST; Maier S; Kempkes B; Cahill PA; Simmons MJ; Gélinas C; Walls D
    J Virol; 2006 Aug; 80(16):8133-44. PubMed ID: 16873269
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
    Zimber-Strobl U; Suentzenich KO; Laux G; Eick D; Cordier M; Calender A; Billaud M; Lenoir GM; Bornkamm GW
    J Virol; 1991 Jan; 65(1):415-23. PubMed ID: 1845900
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.
    Higa M; Kinjo T; Kamiyama K; Iwamasa T; Hamada T; Iyama K
    J Clin Pathol; 2002 Jun; 55(6):414-23. PubMed ID: 12037022
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma.
    Hu LF; Zabarovsky ER; Chen F; Cao SL; Ernberg I; Klein G; Winberg G
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2399-409. PubMed ID: 1681026
    [TBL] [Abstract][Full Text] [Related]  

  • 69. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
    Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Functional cooperation of Epstein-Barr virus nuclear antigen 2 and the survival motor neuron protein in transactivation of the viral LMP1 promoter.
    Voss MD; Hille A; Barth S; Spurk A; Hennrich F; Holzer D; Mueller-Lantzsch N; Kremmer E; Grässer FA
    J Virol; 2001 Dec; 75(23):11781-90. PubMed ID: 11689659
    [TBL] [Abstract][Full Text] [Related]  

  • 71. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.
    Cheung ST; Leung SF; Lo KW; Chiu KW; Tam JS; Fok TF; Johnson PJ; Lee JC; Huang DP
    Int J Cancer; 1998 May; 76(3):399-406. PubMed ID: 9579578
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.
    Tao YG; Tan YN; Liu YP; Song X; Zeng L; Gu HH; Tang M; Li W; Yi W; Cao Y
    Cell Signal; 2004 Jul; 16(7):781-90. PubMed ID: 15115657
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.
    Fåhraeus R; Jansson A; Ricksten A; Sjöblom A; Rymo L
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7390-4. PubMed ID: 2170976
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity.
    Blake SM; Eliopoulos AG; Dawson CW; Young LS
    Virology; 2001 Apr; 282(2):278-87. PubMed ID: 11289810
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.
    Prince S; Keating S; Fielding C; Brennan P; Floettmann E; Rowe M
    J Virol; 2003 Apr; 77(8):5000-7. PubMed ID: 12663807
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.
    Strobl LJ; Höfelmayr H; Marschall G; Brielmeier M; Bornkamm GW; Zimber-Strobl U
    J Virol; 2000 Feb; 74(4):1727-35. PubMed ID: 10644343
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of a novel transcriptional regulatory element within the promoter region of the keratinocyte growth factor gene that mediates inducibility to cyclic AMP.
    Zhou J; Finch PW
    Biochim Biophys Acta; 1999 Jul; 1446(1-2):71-81. PubMed ID: 10395920
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit.
    Ning S; Huye LE; Pagano JS
    J Virol; 2005 Sep; 79(18):11671-6. PubMed ID: 16140744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.